Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin/Gemcitabine Plus Bevacizumab in Advanced NSCLC
NCT00150657Phase 2Unknown
- Sponsor
- Ascension
- Start
- Nov 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Ascension. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00150657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150657.